Constellation Investments’s Celgene Corp CELG Stock Holding History

Constellation Investments’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$3.76M	Buy	37,600 +600	+2%	+$61.8K	0.69%	29
2015 Q4	$4.43M	Buy	37,000 +225	+0.6%	+$26K	0.83%	22
2015 Q3	$3.98M	Buy	36,775 +25	+0.1%	+$3.1K	0.82%	21
2015 Q2	$4.25M	Sell	36,750 -100	-0.3%	-$11.4K	0.81%	22
2015 Q1	$4.25M	Buy	36,850 +1,175	+3%	+$140K	0.81%	24
2014 Q4	$3.99M	Buy	35,675 +1,050	+3%	+$111K	0.81%	22
2014 Q3	$3.28M	Buy	34,625 +175	+0.5%	+$15.8K	0.73%	29
2014 Q2	$2.96M	Sell	34,450 -850	-2%	-$64.6K	0.68%	29
2014 Q1	$2.46M	Buy	35,300 +1,050	+3%	+$83.2K	0.6%	36
2013 Q4	$2.89M	Buy	34,250 +2,450	+8%	+$194K	0.74%	27
2013 Q3	$2.45M	Buy	31,800 +1,500	+5%	+$105K	0.75%	28
2013 Q2	$1.77M	Buy	+30,300	New	+$1.82M	0.61%	40

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Constellation Investments's CELG Position: Q1 2016 in Review

Constellation Investments increased its Celgene Corp (CELG) stake by 1.6% in Q1 2016, buying an estimated $61.8K and bringing the position to 37,600 shares worth $3.76M. The position accounts for 0.69% of the portfolio, ranked #29.

Constellation Investments first reported a position in CELG in Q2 2013 and has held it in 12 quarters since. The position peaked at $4.43M in Q4 2015. 1,224 funds tracked by Wall St. Rank hold CELG as of Q1 2016.

Constellation Investments held 37,600 shares of Celgene Corp worth $3.76M as of Q1 2016.
Constellation Investments bought 600 Celgene Corp shares in Q1 2016, an estimated $61.8K.
Celgene Corp made up 0.69% of Constellation Investments's portfolio in Q1 2016, its #29 holding.
Constellation Investments first reported a position in Celgene Corp in Q2 2013 and has held it in 12 quarters since.
Constellation Investments's Celgene Corp position peaked at $4.43M in Q4 2015.
1,224 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2016.

Based on Constellation Investments's 13F filing for Q1 2016, filed 28 Apr 2016.